	ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
S189-PMC3616124	PMC3616124	4/2013	S189-PMC3616124	['HOWEVER, the pro-oxidant EFFECTS of Vitamin C[28]combined with the reduced antioxidant capacity of Hp 2-2 MAY have CONTRIBUTED to accelerated Coronary Artery narrowing in diabetic Hp 2-2 post-menopausal women taking Vitamins C and E[21].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 106), ('SUPERFICIAL_RELATIONSHIP', 115)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin C'), ('PR_000008793', 'heat shock factor protein 4', 99, 'Hp 2-2'), ('UBERON_0005985', 'coronary vessel', 142, 'coronary'), ('UBERON_0001637', 'artery', 151, 'artery'), ('PR_000008443', 'huntingtin-associated protein 1', 180, 'Hp 2'), ('CHEBI_27300', 'vitamin D', 216, 'vitamins C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 231, 'E')]
S176-PMC3717170	PMC3717170	5/2013	S176-PMC3717170	['CONSISTENTLY, in the longitudinal Aging study amsterdam, low Vitamin D and high Parathyroid hormone were strong, INDEPENDENT RISK FACTORS for loss of muscle strength and muscle mass (sarcopenia).49low Vitamin D levels also APPEAR TO BE CORRELATED with collagen deposition and are RELATED to Arterial stiffness.50the ROLE of Vitamin D in energetics has BEEN LESS THOROUGHLY INVESTIGATED.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 113), ('SUPERFICIAL_RELATIONSHIP', 125), ('ANOMALY_CURIOUS_FINDING', 223), ('SUPERFICIAL_RELATIONSHIP', 236), ('SUPERFICIAL_RELATIONSHIP', 280), ('SUPERFICIAL_RELATIONSHIP', 316), ('ANOMALY_CURIOUS_FINDING', 352), ('INCOMPLETE_EVIDENCE', 357)]	9	[('GO_0007568', 'aging', 34, 'Aging'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 80, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D'), ('UBERON_0001637', 'artery', 291, 'arterial'), ('CHEBI_27300', 'vitamin D', 324, 'vitamin D')]
S2-PMC3882256	PMC3882256	1/2014	S2-PMC3882256	['objective\nTO EXAMINE the RELATIONSHIP between Maternal Pregnancy dietary and supplement iron Intake and hemoglobin, with offspring’s Arterial stiffness (measured by Carotid-radial pulse wave velocity), Endothelial function (measured by Brachial Artery flow mediated dilatation), Blood pressure, and adiposity (measured by body mass index), test for mediation by cord ferritin, Birth weight, Gestational age, and child dietary iron intake, and for EFFECT modification by maternal Vitamin C intake and offspring sex.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('SUPERFICIAL_RELATIONSHIP', 25), ('SUPERFICIAL_RELATIONSHIP', 447)]	3	[('GO_0007618', 'mating', 46, 'maternal'), ('GO_0007565', 'female pregnancy', 55, 'pregnancy'), ('GO_0007631', 'feeding behavior', 93, 'intake'), ('UBERON_0001637', 'artery', 133, 'arterial'), ('UBERON_0005396', 'carotid artery segment', 165, 'carotid'), ('UBERON_0001986', 'endothelium', 202, 'endothelial'), ('UBERON_0001398', 'brachial artery', 236, 'brachial artery'), ('UBERON_0000178', 'blood', 279, 'blood'), ('GO_0007567', 'parturition', 377, 'birth'), ('GO_0007565', 'female pregnancy', 391, 'gestational'), ('CHEBI_27300', 'vitamin D', 479, 'vitamin C')]
S2631-PMC4113768	PMC4113768	7/2014	S2631-PMC4113768	['placebo is SUGGESTIVE of a beneficial EFFECT of Vitamin D supplementation on Arterial stiffness.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 38)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0001637', 'artery', 77, 'arterial')]
S66-PMC4329745	PMC4329745	10/2014	S66-PMC4329745	['insufficient Vitamin D MAY increase the RISK of Colon, Prostate, Breast and skin cancer as well as diabetes types i, multiple sclerosis and Arterial diseases.']	[('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 40)]	2	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('UBERON_0001155', 'colon', 48, 'colon'), ('UBERON_0002367', 'prostate gland', 55, 'prostate'), ('UBERON_0000310', 'breast', 65, 'breast'), ('UBERON_0001637', 'artery', 140, 'arterial')]
S144-PMC4377870	PMC4377870	3/2015	S144-PMC4377870	['in vitro studies also SUPPORT the LINK between Vitamin D and Airway Remodelling AS active Vitamin D inhibits Airway Smooth Muscle (Asm) Cell Proliferation [114] and deficiency impairs normal Lung Development [115].']	[('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 34), ('PROBABLE_UNDERSTANDING', 80)]	3	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0003313', 'heart rudiment development', 61, 'airway remodelling'), ('UBERON_0001005', 'respiratory airway', 61, 'airway'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('CL_0002633', 'respiratory basal cell', 109, 'airway smooth muscle ... cell'), ('UBERON_0001005', 'respiratory airway', 109, 'airway'), ('GO_0007585', 'respiratory gaseous exchange by respiratory system', 116, 'smooth muscle'), ('UBERON_0001135', 'smooth muscle tissue', 116, 'smooth muscle'), ('UBERON_0001637', 'artery', 131, 'ASM'), ('GO_0008283', 'cell proliferation', 136, 'cell proliferation'), ('GO_0030324', 'lung development', 191, 'lung development'), ('UBERON_0002048', 'lung', 191, 'lung')]
S6-PMC4600246	PMC4600246	10/2015	S6-PMC4600246	['moreover, a normal carboxylated mgp protein in the Serum MAY NOT NECESSARILY INDICATE a normal Vitamin K status, AS carboxylated mgp in the Serum COULD BE normal, BUT suboptimal in the Arteries (where Vitamin K2Is needed to prevent vascular calcification.)']	[('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 77), ('PROBABLE_UNDERSTANDING', 113), ('INCOMPLETE_EVIDENCE', 146), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 163)]	6	[('UBERON_0001977', 'blood serum', 51, 'serum'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin K'), ('UBERON_0001977', 'blood serum', 140, 'serum'), ('UBERON_0001637', 'artery', 185, 'arteries'), ('CHEBI_35684', 'antiplatyhelmintic drug', 201, 'vitamin K2is')]
S16-PMC4600246	PMC4600246	10/2015	S16-PMC4600246	['this was NOT SHOWN with vitamin k1intake (Phylloquinone, the major dietary source of Vitamin K.2627thus, dietary vitamin k1intake, without Vitamin K2, MAY not be sufficient to suppress Arterial calcifications and/or reduce RISK for subsequent Cardiovascular events and death.']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 151), ('IMPORTANT_CONSIDERATION', 223)]	3	[('CHEBI_26124', 'phytosteroid', 42, 'phylloquinone'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin K'), ('CHEBI_28934', 'vitamin D2', 139, 'vitamin K2'), ('UBERON_0001637', 'artery', 185, 'arterial'), ('UBERON_0004535', 'cardiovascular system', 243, 'cardiovascular')]
S17-PMC4600246	PMC4600246	10/2015	S17-PMC4600246	['the Menaquinone form of Vitamin K (ie, Vitamin K2) HAS BEEN PRESUMED to be more effective than Vitamin K1At preventing and reversing Arterial calcifications.']	[('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 60), ('PROBABLE_UNDERSTANDING', 60)]	3	[('CHEBI_18154', 'polysaccharide', 4, 'menaquinone'), ('CHEBI_27300', 'vitamin D', 24, 'vitamin K'), ('CHEBI_28934', 'vitamin D2', 39, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 39, 'vitamin K2'), ('CHEBI_83630', 'essential oil', 95, 'vitamin K1at'), ('PR_000009486', 'keratin, type II cytoskeletal 71', 103, 'K1at'), ('UBERON_0001637', 'artery', 133, 'arterial')]
S27-PMC4600246	PMC4600246	10/2015	S27-PMC4600246	['low levels of Vitamin K impair activation of Osteocalcin and decrease the activity of Osteoblasts (cells IMPORTANT for building bone).3334thus, Vitamin K is VITAL to the functionality of proteins such as Osteocalcin (IMPORTANT for building bone), (mgp, the most potent Arterial Calcification Inhibitor known) and the growth-arrest sequence-6 protein (Gas6, INVOLVED in Cell Growth Regulation35\nVitamin K HAS BEEN SHOWN to significantly delay the development of cac in a 3-year, double-blind, randomised controlled trial of 452 patients (229 patients on Vitamin K1And 223 patients in the control group).36all patients were assigned to a multivitamin (containing 1.6\u2005mg Thiamine, 1.8\u2005mg riboflavin, 2.1\u2005mg Vitamin B-6, 3\u2005µg Vitamin B12, 75\u2005mg Vitamin C, 12\u2005mg Vitamin E, 6\u2005mg Pantothenic Acid, 20\u2005mg niacin, 160\u2005µg Folate and 30\u2005µg of Biotin) as well as calcium (600\u2005mg Calcium Carbonate) and Vitamin D (Cholecalciferol 400\u2005iu).']	[('IMPORTANT_CONSIDERATION', 105), ('IMPORTANT_CONSIDERATION', 157), ('IMPORTANT_CONSIDERATION', 217), ('SUPERFICIAL_RELATIONSHIP', 357), ('INCOMPLETE_EVIDENCE', 404)]	5	[('CHEBI_27300', 'vitamin D', 14, 'vitamin K'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 45, 'osteocalcin'), ('CL_0000062', 'osteoblast', 86, 'osteoblasts'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin K'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 204, 'osteocalcin'), ('UBERON_0001637', 'artery', 269, 'arterial'), ('GO_0051301', 'cell division', 278, 'calcification'), ('CHEBI_35222', 'inhibitor', 292, 'inhibitor'), ('PR_000008000', 'gap junction beta-4 protein', 351, 'Gas6'), ('GO_0071475', 'cellular hyperosmotic salinity response', 369, 'cell growth regulation35'), ('CHEBI_28384', 'vitamin K', 394, 'Vitamin K'), ('CHEBI_10124', 'zolmitriptan', 553, 'vitamin K1and'), ('PR_000017209', 'utrophin', 553, 'vitamin K1and'), ('CHEBI_26948', 'vitamin B1', 668, 'thiamine'), ('CHEBI_27300', 'vitamin D', 704, 'vitamin B'), ('CHEBI_33279', 'vitamin D5', 722, 'vitamin B12'), ('CHEBI_27300', 'vitamin D', 741, 'vitamin C'), ('CHEBI_27300', 'vitamin D', 758, 'vitamin E'), ('CHEBI_7916', 'pantothenic acid', 774, 'pantothenic acid'), ('CHEBI_30863', '5-azaorotic acid', 813, 'folate'), ('CHEBI_15956', 'biotin', 833, 'biotin'), ('CHEBI_3311', 'calcium carbonate', 868, 'calcium carbonate'), ('CHEBI_27300', 'vitamin D', 891, 'vitamin D'), ('CHEBI_52550', 'theopalauamide', 902, 'cholecalciferol')]
S37-PMC4600246	PMC4600246	10/2015	S37-PMC4600246	['Vitamin K administration HAS BEEN SHOWN to significantly delay the progression of cac and, in addition, it HAS also BEEN shown to significantly delay the deterioration of Arterial elasticity.37in another 3-year, double-blind, placebo-controlled trial, Vitamin D and Vitamin K were INVESTIGATED.']	[('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 107), ('QUESTION_ANSWERED_BY_THIS_WORK', 281)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin K'), ('UBERON_0001637', 'artery', 171, 'arterial'), ('CHEBI_27300', 'vitamin D', 252, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin K')]
S41-PMC4600246	PMC4600246	10/2015	S41-PMC4600246	['IN SUMMARY, Vitamin K1Along with Vitamin D has beneficial EFFECTS on Arterial elasticity.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 58)]	2	[('CHEBI_33229', 'vitamin (role)', 12, 'vitamin'), ('PR_000009209', 'juxtaposed with another zinc finger protein 1', 20, 'K1along'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0001637', 'artery', 69, 'arterial')]
S42-PMC4600246	PMC4600246	10/2015	S42-PMC4600246	['Vitamin K and warfarin\nsince warfarin directly leads to the inhibition of Vitamin K, it would be PRESUMED that there COULD BE increased Arterial calcifications in patients given warfarin.']	[('PROBABLE_UNDERSTANDING', 97), ('INCOMPLETE_EVIDENCE', 117)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin K'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin K'), ('UBERON_0001637', 'artery', 136, 'arterial')]
S44-PMC4600246	PMC4600246	10/2015	S44-PMC4600246	['furthermore, most Individuals taking warfarin are counselled to avoid Vitamin K-containing foods, such as green leafy vegetables, which MAY lead to an EVEN further increase in cac.36vitamin k deficiency CAN be exacerbated further when Warfarin is initiated.38the negative IMPACT that warfarin CAN have on the body HAS LONG BEEN RECOGNISED.39\nwarfarin HAS BEEN SHOWN to cause SEVERE Arterial calcifications in the Aorta and the Carotid Arteries of Rats.']	[('INCOMPLETE_EVIDENCE', 136), ('ANOMALY_CURIOUS_FINDING', 151), ('INCOMPLETE_EVIDENCE', 203), ('SUPERFICIAL_RELATIONSHIP', 272), ('INCOMPLETE_EVIDENCE', 293), ('INCOMPLETE_EVIDENCE', 314), ('PROBABLE_UNDERSTANDING', 318), ('PROBABLE_UNDERSTANDING', 328), ('INCOMPLETE_EVIDENCE', 351), ('IMPORTANT_CONSIDERATION', 375)]	10	[('NCBITaxon_1', 'root', 18, 'individuals'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin K'), ('CHEBI_10033', 'warfarin', 235, 'warfarin'), ('UBERON_0001637', 'artery', 382, 'arterial'), ('UBERON_0000947', 'aorta', 413, 'aorta'), ('UBERON_0005396', 'carotid artery segment', 427, 'carotid arteries'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 447, 'rats')]
S46-PMC4600246	PMC4600246	10/2015	S46-PMC4600246	['moreover, high-dose Vitamin K1Or Vitamin K2Restored Arterial distensibility back to that SEEN in control Rats.38thus, Animal data INDICATE that Vitamin K (k1or k2) MAY BE able to reverse Arterial calcifications and at the same time improve Arterial compliance.']	[('INCOMPLETE_EVIDENCE', 89), ('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 164)]	3	[('CHEBI_31633', 'formoterol fumarate', 20, 'vitamin K1or'), ('CHEBI_51197', 'calixaromatic', 33, 'vitamin K2restored'), ('UBERON_0001637', 'artery', 52, 'arterial'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 105, 'rats'), ('NCBITaxon_33208', 'Metazoa', 118, 'animal'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin K'), ('UBERON_0001637', 'artery', 187, 'arterial'), ('UBERON_0001637', 'artery', 240, 'arterial')]
S50-PMC4600246	PMC4600246	10/2015	S50-PMC4600246	['it HAS BEEN PRESUMED that Prenatal Vitamin K deficiency induced by warfarin MAY BE the UNDERLYING cause of these calcifications.4344indeed, SEVERAL STUDIES INDICATE a CONNECTION between warfarin and Arterial calcifications.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 87), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 156), ('SUPERFICIAL_RELATIONSHIP', 167)]	8	[('GO_0007565', 'female pregnancy', 26, 'prenatal'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin K'), ('UBERON_0001637', 'artery', 199, 'arterial')]
S77-PMC4600246	PMC4600246	10/2015	S77-PMC4600246	['finally, in the RECENT vitamin k italian (viki) dialysis STUDY, 23.5% of patients were FOUND to be Vitamin K deficient, and this deficiency was FOUND TO BE the strongest PREDICTOR of vertebral fractures (or: 2.94; 95% ci 1.38 to 6.26).72other data HAVE SHOWN that vitamin K2May improve Bone Remodelling in patients with haemodialysis with low Serum Parathyroid hormone levels.73supplementing with at LEAST 200\u2005µg Menaquinone-7 (a form of Vitamin K2) daily MAY help to achieve near maximal protection from vascular calcification, osteoporosis and cancer (measured by maximal gamma carboxylation of Vitamin K dependent proteins).35\n\nconclusion\nVitamin K has a plethora of POTENTIAL IMPLICATIONS, including prevention and treatment of Arterial calcifications, Coronary Heart disease and cancer, improvements in bone strength and reduced risks of fractures as well as improvements in Insulin sensitivity.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 87), ('ANOMALY_CURIOUS_FINDING', 144), ('SUPERFICIAL_RELATIONSHIP', 170), ('INCOMPLETE_EVIDENCE', 248), ('PROBABLE_UNDERSTANDING', 400), ('INCOMPLETE_EVIDENCE', 456), ('INCOMPLETE_EVIDENCE', 670), ('IMPORTANT_CONSIDERATION', 680)]	10	[('CHEBI_27300', 'vitamin D', 99, 'vitamin K'), ('PR_000009481', 'keratin, type II cytoskeletal 5', 272, 'K2may'), ('GO_0046849', 'bone remodeling', 286, 'bone remodelling'), ('UBERON_0001977', 'blood serum', 343, 'serum'), ('UBERON_0001132', 'parathyroid gland', 349, 'parathyroid'), ('CHEBI_18154', 'polysaccharide', 413, 'menaquinone'), ('CHEBI_28934', 'vitamin D2', 438, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 438, 'vitamin K2'), ('CHEBI_27300', 'vitamin D', 597, 'vitamin K'), ('CHEBI_28384', 'vitamin K', 642, 'Vitamin K'), ('UBERON_0001637', 'artery', 732, 'arterial'), ('UBERON_0004151', 'cardiac chamber', 757, 'coronary heart'), ('PR_000045358', 'insulin family protein', 880, 'insulin')]
S79-PMC4600246	PMC4600246	10/2015	S79-PMC4600246	['on THE BASIS of PREVIOUSLY PRESENTED data, Warfarin MAY increase Arterial calcifications and osteoporosis through the inhibition of Vitamin K. LARGER TRIALS SHOULD BE performed to FURTHER ELUCIDATE the negative long-term health CONSEQUENCES of warfarin and IF these CAN PERHAPS be PREVENTED through the institution of supplemental Vitamin K.\n\npubmed central:']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 52), ('FUTURE_WORK', 143), ('FUTURE_WORK', 157), ('FUTURE_WORK', 180), ('INCOMPLETE_EVIDENCE', 188), ('PROBLEM_COMPLICATION', 228), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 257), ('INCOMPLETE_EVIDENCE', 266), ('INCOMPLETE_EVIDENCE', 270), ('SUPERFICIAL_RELATIONSHIP', 281)]	12	[('CHEBI_10033', 'warfarin', 43, 'warfarin'), ('UBERON_0001637', 'artery', 65, 'arterial'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 331, 'vitamin K')]
S16-PMC5085625	PMC5085625	9/2016	S16-PMC5085625	['the active form of Vitamin D, i.e., 1,25(Oh)2D, is now recognized as an IMPORTANT hormone playing a CRUCIAL role in Skeletal Homeostasis (classical effects) and exerting NON-CLASSICAL EFFECTS in various pathological and physiological conditions, such as cancer, Arterial hypertension, Cardiovascular diseases, Brain Development and Immunomodulation [3,4,5,6].']	[('IMPORTANT_CONSIDERATION', 72), ('IMPORTANT_CONSIDERATION', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('SUPERFICIAL_RELATIONSHIP', 184)]	4	"[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_66212', ""5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone"", 38, '25(OH)2D'), ('GO_0043276', 'anoikis', 116, 'skeletal homeostasis'), ('UBERON_0004288', 'skeleton', 116, 'skeletal'), ('UBERON_0001637', 'artery', 262, 'arterial'), ('UBERON_0004535', 'cardiovascular system', 285, 'cardiovascular'), ('GO_0007420', 'brain development', 310, 'brain development'), ('UBERON_0000955', 'brain', 310, 'brain'), ('GO_0050900', 'leukocyte migration', 332, 'immunomodulation')]"
S22-PMC5129897	PMC5129897	10/2016	S22-PMC5129897	['diseases included in THIS STUDY along with a brief overview of the mechanisms of Vitamin D for each disease and a listing of a few observational studies and clinical trials in support.diseasemechanismsobservational studiesclinical trialscancereffects on cells, Angiogenesis, and metastasis10breast and Colorectal cancer incidence11; survival12breast and all-cancer incidence13cvdeffects on Serum Cholesterol levels, Arterial stiffness, Insulin resistance, hyperglycemia, and increased incident Metabolic syndrome are POTENTIALLY PLAUSIBLE mediators8refs.14,15effect on cvd risk factors16dementiaregulation of Calcium Homeostasis, clearance of Amyloid-Β peptide, antioxidant and anti-inflammatory EFFECTS, and POSSIBLE protection against the neurodegenerative mechanisms ASSOCIATED with ad17incidence18\xa0dmimproves Insulin sensitivity and secretion, mainly via its anti-inflammatory properties19incidence20; meta-analysis21\xa0falls and fracturesreduces bone mass loss by reducing inflammation22; maintains cognition23; helps maintain muscle mass24ref.25ref.26mseffects on Regulatory T and B Cells27Ref.28\xa0respiratory infectionsinduction of Cathelicidin and defensins29; strengthens Adaptive and innate Immune System30Pneumonia31Influenza32,33; ari34\nad, alzheimer disease; ari, acute Respiratory Tract infection; cvd, Cardiovascular disease; dm, diabetes mellitus; ms, multiple sclerosis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('INCOMPLETE_EVIDENCE', 517), ('INCOMPLETE_EVIDENCE', 529), ('SUPERFICIAL_RELATIONSHIP', 696), ('INCOMPLETE_EVIDENCE', 709), ('SUPERFICIAL_RELATIONSHIP', 770)]	6	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0001525', 'angiogenesis', 261, 'angiogenesis'), ('UBERON_0012652', 'colorectum', 302, 'colorectal'), ('UBERON_0001977', 'blood serum', 390, 'serum'), ('CHEBI_16113', 'cholesterol', 396, 'cholesterol'), ('UBERON_0001637', 'artery', 416, 'arterial'), ('PR_000045358', 'insulin family protein', 436, 'insulin'), ('GO_0008152', 'metabolic process', 494, 'metabolic'), ('GO_0055073', 'cadmium ion homeostasis', 609, 'calcium homeostasis'), ('PR_000004519', 'autism susceptibility gene 2 protein', 643, 'amyloid-β'), ('PR_000045358', 'insulin family protein', 813, 'insulin'), ('CL_0000815', 'regulatory T cell', 1068, 'regulatory T ...'), ('GO_0065007', 'biological regulation', 1068, 'regulatory'), ('CL_0000960', 'T3 B cell', 1085, 'B cells27Ref'), ('PR_000006009', 'alpha-catulin', 1136, 'cathelicidin'), ('GO_0051886', 'negative regulation of timing of anagen', 1178, 'adaptive ...'), ('UBERON_0003822', 'forelimb stylopod', 1198, 'immune system30Pneumonia31Influenza32'), ('UBERON_0000065', 'respiratory tract', 1280, 'respiratory tract'), ('UBERON_0004535', 'cardiovascular system', 1314, 'cardiovascular')]
S496-PMC5941617	PMC5941617	5/2018	S496-PMC5941617	['in a 16-week rct with 2000\xa0iu/day of Vitamin D authors REPORTED that therapy was able to reduce Arterial stiffness in black obese adolescents [151].']	[('INCOMPLETE_EVIDENCE', 55)]	1	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0001637', 'artery', 96, 'arterial')]
S78-PMC5513133	PMC5513133	7/2017	S78-PMC5513133	['in ONE STUDY, oral Vitamin D2 (vd2, 270\xa0iu/day) and Vitamin D3 (vd3, 15\xa0iu/day) lowered mean Arterial blood pressure (mm\xa0hg) in Pregnant Rats infused with Autoantibodies to Angiotensin Ii Type I Receptor (vd2: 105 +/−2, vd3: 109 +/− 2) versus Rats that were infused with Autoantibodies to Angiotensin Ii Type I Receptor but did not receive oral vd2 or vd3 (121 +/− 4) [64].']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_28934', 'vitamin D2', 19, 'vitamin D2'), ('PR_000017299', 'VIP peptides', 19, 'vitamin D2'), ('CHEBI_33279', 'vitamin D5', 52, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 52, 'vitamin D3'), ('UBERON_0001637', 'artery', 93, 'arterial'), ('GO_0007565', 'female pregnancy', 128, 'pregnant'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 137, 'rats'), ('GO_0044308', 'axonal spine', 155, 'autoantibodies'), ('PR_000001683', 'vasopressin V2 receptor', 173, 'Angiotensin II type I receptor'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 243, 'rats'), ('GO_0044308', 'axonal spine', 271, 'autoantibodies'), ('PR_000001683', 'vasopressin V2 receptor', 289, 'Angiotensin II type I receptor')]
